Share on StockTwits

Bio-Reference Laboratories (NASDAQ:BRLI) is set to issue its Q314 quarterly earnings data on Wednesday, August 27th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $210.44 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Bio-Reference Laboratories (NASDAQ:BRLI) last announced its earnings results on Thursday, June 5th. The company reported $0.37 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.32 by $0.05. The company had revenue of $201.30 million for the quarter, compared to the consensus estimate of $0.20 million. During the same quarter in the prior year, the company posted $0.41 earnings per share. The company’s quarterly revenue was up 14.1% on a year-over-year basis. On average, analysts expect Bio-Reference Laboratories to post $1.64 EPS for the current fiscal year and $1.95 EPS for the next fiscal year.

Shares of Bio-Reference Laboratories (NASDAQ:BRLI) opened at 31.78 on Tuesday. Bio-Reference Laboratories has a 52-week low of $24.13 and a 52-week high of $37.97. The stock’s 50-day moving average is $31.34 and its 200-day moving average is $28.38. The company has a market cap of $880.8 million and a price-to-earnings ratio of 22.86.

Bio-Reference Laboratories, Inc (NASDAQ:BRLI) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units.

Receive News & Ratings for Bio-Reference Laboratories Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Reference Laboratories Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.